SIRT5 and obesity due to melanocortin 4 receptor deficiency: Because SIRT5 is essential in preserving BAT/WAT balance, and since BAT is involved in glucose homeostasis, SIRT5 may be a target for the therapy of certain metabolic diseases such as obesity and type 2 diabetes [93].